April 30, 2021
A key health ministry panel gave the thumbs-up to Bayer Yakuhin’s soluble guanylate cyclase (sGC) stimulator vericiguat for the treatment of chronic heart failure on April 28, putting it in line for regulatory approval as early as June. Vericiguat was...read more